Methods for treating ocular angiogenesis, retinal edema, retinal ischemia, and diabetic retinopathy using selective RTK inhibitors

Details for Australian Patent Application No. 2006216567 (hide)

Owner Alcon, Inc.

Inventors Bingaman, David P.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006216567

PCT Pub. Number WO2006/091801

Priority 60/655,676 23.02.05 US

Filing date 23 February 2006

Wipo publication date 31 August 2006

Acceptance publication date 13 October 2011

International Classifications

A61K 31/00 (2006.01)

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

A61K 31/423 (2006.01) - condensed with carbocyclic rings

A61P 27/02 (2006.01) Drugs for disorders of the senses

Event Publications

11 October 2007 PCT application entered the National Phase

  PCT publication WO2006/091801 Priority application(s): WO2006/091801

13 October 2011 Application Accepted

  Published as AU-B-2006216567

9 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006216573-Bone implants

2006216566-Novel pyridine derivatives as potassium ion channel openers